Patent holdings for IPC class A61K 31/439

Total number of patents in this class: 2181

10-year publication summary

254
203
180
191
201
205
177
183
154
31
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Wockhardt Limited
239
50
Novartis AG
11238
40
Genzyme Corporation
1205
35
AstraZeneca AB
3042
31
Chiesi Farmaceutici S.p.A.
940
31
Bristol-myers Squibb Company
5080
26
Boehringer Ingelheim International GmbH
4629
26
Lenz Therapeutics Operations, Inc.
31
26
Merck Sharp & Dohme LLC
3689
24
Meiji Seika Pharma Co., Ltd.
244
23
Theravance Biopharma R&D IP, LLC
550
20
Astellas Pharma Inc.
1145
19
Glaxo Group Limited
4496
16
Centre National de La Recherche Scientifique
9632
16
Vertex Pharmaceuticals Incorporated
1581
16
The Scripps Research Institute
1364
15
Pfizer Inc.
3322
13
Heron Therapeutics, Inc.
156
13
Aprea Therapeutics AB
16
13
Mutabilis
27
12
Other owners 1716